Cargando…

Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome

Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Bin, Chen, Shanshan, Ryan, Kathleen A., Maitland, Michael L., Farrar, Jared S., Witzenrath, Martin, Gubier, Birgitt, Serdjebi, Cindy, Bertotti, Karine, Wang, Rui, Salloum, Fadi N., Marino, Luigi, Mitchell, Braxton D., Celi, Francesco S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486017/
https://www.ncbi.nlm.nih.gov/pubmed/36055577
http://dx.doi.org/10.1016/j.molmet.2022.101588
_version_ 1784792185521045504
author Ni, Bin
Chen, Shanshan
Ryan, Kathleen A.
Maitland, Michael L.
Farrar, Jared S.
Witzenrath, Martin
Gubier, Birgitt
Serdjebi, Cindy
Bertotti, Karine
Wang, Rui
Salloum, Fadi N.
Marino, Luigi
Mitchell, Braxton D.
Celi, Francesco S.
author_facet Ni, Bin
Chen, Shanshan
Ryan, Kathleen A.
Maitland, Michael L.
Farrar, Jared S.
Witzenrath, Martin
Gubier, Birgitt
Serdjebi, Cindy
Bertotti, Karine
Wang, Rui
Salloum, Fadi N.
Marino, Luigi
Mitchell, Braxton D.
Celi, Francesco S.
author_sort Ni, Bin
collection PubMed
description Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat vascularization, which is a precondition for the transport of substrate and the dissipation of heat. Angiopoietin-2 is an important driver of vascularization, and its transcription is in part promoted by estrogen signaling. In this study we demonstrate that adipose tissue-specific knock out of Angiopoietin-2 causes a female-specific reduced thermogenic fat differentiation and function, resulting in obesity and impaired glucose tolerance with end-organ features consistent with metabolic syndrome. In humans, angiopoietin-2 levels are higher in females than in males, and are inversely correlated with adiposity and age more strongly in pre-menopause when compared to post-menopause. Collectively, these data indicate a novel and important role for estrogen-mediated Angiopoietin-2 adipose tissue production in the protection against calorie overload in females, and potentially in the development of postmenopausal weight gain.
format Online
Article
Text
id pubmed-9486017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94860172022-09-21 Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome Ni, Bin Chen, Shanshan Ryan, Kathleen A. Maitland, Michael L. Farrar, Jared S. Witzenrath, Martin Gubier, Birgitt Serdjebi, Cindy Bertotti, Karine Wang, Rui Salloum, Fadi N. Marino, Luigi Mitchell, Braxton D. Celi, Francesco S. Mol Metab Original Article Thermogenic fat differentiation and function can be promoted through multiple pathways, resulting in a common cell phenotype characterized by the expression of Uncoupling Protein-1 and the ability to dissipate energy, but local and systemic stimuli are necessary to promote adequate thermogenic fat vascularization, which is a precondition for the transport of substrate and the dissipation of heat. Angiopoietin-2 is an important driver of vascularization, and its transcription is in part promoted by estrogen signaling. In this study we demonstrate that adipose tissue-specific knock out of Angiopoietin-2 causes a female-specific reduced thermogenic fat differentiation and function, resulting in obesity and impaired glucose tolerance with end-organ features consistent with metabolic syndrome. In humans, angiopoietin-2 levels are higher in females than in males, and are inversely correlated with adiposity and age more strongly in pre-menopause when compared to post-menopause. Collectively, these data indicate a novel and important role for estrogen-mediated Angiopoietin-2 adipose tissue production in the protection against calorie overload in females, and potentially in the development of postmenopausal weight gain. Elsevier 2022-08-30 /pmc/articles/PMC9486017/ /pubmed/36055577 http://dx.doi.org/10.1016/j.molmet.2022.101588 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Ni, Bin
Chen, Shanshan
Ryan, Kathleen A.
Maitland, Michael L.
Farrar, Jared S.
Witzenrath, Martin
Gubier, Birgitt
Serdjebi, Cindy
Bertotti, Karine
Wang, Rui
Salloum, Fadi N.
Marino, Luigi
Mitchell, Braxton D.
Celi, Francesco S.
Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
title Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
title_full Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
title_fullStr Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
title_full_unstemmed Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
title_short Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome
title_sort selective adipocyte loss of angiopoietin-2 prompts female-specific obesity and metabolic syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486017/
https://www.ncbi.nlm.nih.gov/pubmed/36055577
http://dx.doi.org/10.1016/j.molmet.2022.101588
work_keys_str_mv AT nibin selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT chenshanshan selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT ryankathleena selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT maitlandmichaell selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT farrarjareds selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT witzenrathmartin selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT gubierbirgitt selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT serdjebicindy selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT bertottikarine selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT wangrui selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT salloumfadin selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT marinoluigi selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT mitchellbraxtond selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome
AT celifrancescos selectiveadipocytelossofangiopoietin2promptsfemalespecificobesityandmetabolicsyndrome